IT202200008894A1 - Nutraceutical composition including citicoline, vitamin D3 and hemp oil. - Google Patents
Nutraceutical composition including citicoline, vitamin D3 and hemp oil. Download PDFInfo
- Publication number
- IT202200008894A1 IT202200008894A1 IT102022000008894A IT202200008894A IT202200008894A1 IT 202200008894 A1 IT202200008894 A1 IT 202200008894A1 IT 102022000008894 A IT102022000008894 A IT 102022000008894A IT 202200008894 A IT202200008894 A IT 202200008894A IT 202200008894 A1 IT202200008894 A1 IT 202200008894A1
- Authority
- IT
- Italy
- Prior art keywords
- citicoline
- vitamin
- composition including
- nutraceutical composition
- hemp oil
- Prior art date
Links
- RZZPDXZPRHQOCG-OJAKKHQRSA-M CDP-choline(1-) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-M 0.000 title 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title 1
- 229960001284 citicoline Drugs 0.000 title 1
- 239000010460 hemp oil Substances 0.000 title 1
- 239000002417 nutraceutical Substances 0.000 title 1
- 235000021436 nutraceutical agent Nutrition 0.000 title 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 title 1
- 235000005282 vitamin D3 Nutrition 0.000 title 1
- 239000011647 vitamin D3 Substances 0.000 title 1
- 229940021056 vitamin d3 Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102022000008894A IT202200008894A1 (en) | 2022-05-03 | 2022-05-03 | Nutraceutical composition including citicoline, vitamin D3 and hemp oil. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102022000008894A IT202200008894A1 (en) | 2022-05-03 | 2022-05-03 | Nutraceutical composition including citicoline, vitamin D3 and hemp oil. |
Publications (1)
Publication Number | Publication Date |
---|---|
IT202200008894A1 true IT202200008894A1 (en) | 2023-11-03 |
Family
ID=82482570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102022000008894A IT202200008894A1 (en) | 2022-05-03 | 2022-05-03 | Nutraceutical composition including citicoline, vitamin D3 and hemp oil. |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT202200008894A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015031637A1 (en) * | 2013-08-29 | 2015-03-05 | Abbott Laboratories | Nutritional composition having lipophilic compounds with improved solubility and bioavailability |
US20160038552A1 (en) * | 2013-03-15 | 2016-02-11 | Buck Institute For Research On Aging | Improved cognitive supplements |
WO2017136775A1 (en) * | 2016-02-04 | 2017-08-10 | Czap Research And Development, Llc | Controlled-release and stratified cyclodextrin inclusion complex vehicles |
WO2019064245A1 (en) * | 2017-09-29 | 2019-04-04 | Neilos S.r.l. | A composition for use in the prevention and/or treatment of glaucoma |
US20200170272A1 (en) * | 2018-11-30 | 2020-06-04 | Virun, Inc. | Creamy edible emulsions |
IT201900025069A1 (en) * | 2019-12-20 | 2021-06-20 | Alidans S R L | ORAL COMPOSITION TO PROMOTE THE REGENERATION OF PERIPHERAL NERVES |
-
2022
- 2022-05-03 IT IT102022000008894A patent/IT202200008894A1/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160038552A1 (en) * | 2013-03-15 | 2016-02-11 | Buck Institute For Research On Aging | Improved cognitive supplements |
WO2015031637A1 (en) * | 2013-08-29 | 2015-03-05 | Abbott Laboratories | Nutritional composition having lipophilic compounds with improved solubility and bioavailability |
WO2017136775A1 (en) * | 2016-02-04 | 2017-08-10 | Czap Research And Development, Llc | Controlled-release and stratified cyclodextrin inclusion complex vehicles |
WO2019064245A1 (en) * | 2017-09-29 | 2019-04-04 | Neilos S.r.l. | A composition for use in the prevention and/or treatment of glaucoma |
US20200170272A1 (en) * | 2018-11-30 | 2020-06-04 | Virun, Inc. | Creamy edible emulsions |
IT201900025069A1 (en) * | 2019-12-20 | 2021-06-20 | Alidans S R L | ORAL COMPOSITION TO PROMOTE THE REGENERATION OF PERIPHERAL NERVES |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112017018276A2 (en) | ? composition comprising peptidase and biotensive agent and their use? | |
CL2019003798A1 (en) | Methods to treat huntington's disease. | |
UY35582A (en) | COMPOSITIONS OF ARNi DE SERPINA1 AND ITS METHODS OF USE | |
AR060387A1 (en) | FOOD SUPPLEMENTS AND THEIR USES | |
SV2009002899A (en) | DIARILURES FOR THE TREATMENT OF PULMONARY HYPERTENSION | |
ECSP099654A (en) | METHODS TO PRODUCE HAPLOID AND DOUBLE HAPLOID OIL PALM PLANTS | |
ECSP099794A (en) | ALFA-ENaC EXPRESSION RNAi INHIBITION | |
CO2019000787A2 (en) | New formulations and compositions of cannabis in tablets and methods for its elaboration | |
CO6361894A2 (en) | CLEARING COMPOSITIONS OF THE SKIN WITH ACETILCOLINESTERASE INHIBITORS | |
CL2018000525A1 (en) | Spinosin derivatives and preparation methods. | |
CO2021017697A2 (en) | Improvements in or related to organic compounds | |
BR112018007384A2 (en) | reduction of pungent skin sensation | |
AR104263A1 (en) | COMPOSITIONS OF FRACTURING FLUID WITH MICROUPUNDS TO IMPROVE THE PERFORMANCE OF THE COMPLEX FRACTURE NETWORK | |
UY36967A (en) | TREATMENT OF OLIGO-OVULATION RELATED TO HEPATIC ESTEATOSIS | |
BR112012023300A2 (en) | MATRIX TO CO-EXTRUD A PLURALITY OF FLUID LAYERS | |
CL2019003072A1 (en) | Encapsulated nutritional and pharmaceutical compositions. | |
BR112017019309A2 (en) | Method for preparing confectionery fillings | |
BR112018072816A2 (en) | juice products and methods for reduced enzymatic browning | |
BR112015013012A2 (en) | bar soap composition and method for its manufacture | |
BR112021000279A8 (en) | tumor reduction formulations and methods of using them | |
IT202200008894A1 (en) | Nutraceutical composition including citicoline, vitamin D3 and hemp oil. | |
CL2018002885A1 (en) | Provide a method to significantly enhance the effects of plant disease control, and a method to control plant diseases | |
BR112022000314A2 (en) | Reducing malaria transmission | |
BR112017020324A2 (en) | colored inorganic peroxide compositions and hydraulic fracturing fluid breaking methods | |
UY38078A (en) | COMPOSITION OF A LUBRICANT AND METHOD FOR PREPARATION |